MedPath

The Effect of Exercises on Physiological Changes and Clinical Symptoms in Allergic Rhinitis Patients

Not Applicable
Completed
Conditions
Allergic Rhinitis
Interventions
Other: Aerobic exercise with Vit. C
Other: Aerobic exercise
Other: No exercise
Registration Number
NCT02123914
Lead Sponsor
Chulalongkorn University
Brief Summary

1. Moderate exercise training decrease cytokine response and rhinitis symptoms in patients with allergic rhinitis

2. Moderate exercise training combined with vitamin C supplementation decrease cytokine response and rhinitis symptoms in patients with allergic rhinitis

3. Moderate exercise training combined with vitamin C supplementation has more beneficial effects than moderate exercise training alone for decreasing cytokine response and rhinitis symptoms in patients with allergic rhinitis

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
27
Inclusion Criteria

The inclusion criteria included patients with allergic rhinitis who had a clinical history of persistent rhinitis, and had positive skin prick test (wheal diameter ≥ 3 mm) to house dust mite (D. pteronyssinus).

Exclusion Criteria

Subjects with known asthma, chronic rhinosinusitis, hypertension or cardiovascular diseases were excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Aerobic exercise with Vit. C & Aerobic exerciseAerobic exercise-
exercise without vit. c supplement & no exerciseAerobic exercise with Vit. C-
Aerobic exercise with Vit. C & Aerobic exerciseAerobic exercise with Vit. C-
exercise without vit. c supplement & no exerciseNo exercise-
Primary Outcome Measures
NameTimeMethod
Changes from baseline in rhinitis symptomsBaseline, week 8

Nasal symptoms will be assessed using a rhinitis symptom score questionnaire. The subjects will be asked to score symptoms of persistent allergic rhinitis; nasal congestion, itching, sneezing, and rhinorrhea before and after each exercise protocol. The score ranged from 0 to 3 points (0 = none, 1 = mild, 2 = moderate, 3 = severe).

Changes from baseline in cytokinebaseline, week 8

The cytokines IL-2, IL-4, and IL-13 in blood and nasal secretion will be determined by using the flow cytometry technique (Scavuzzo MC. et al., 2003). Data will be acquired using a flow cytometer (BD FACSCalibur Flow Cytometer, USA) and analyzed by FlowcytomixTM Pro software (eBioscience, USA.).

Secondary Outcome Measures
NameTimeMethod
Changes from baseline in pulmonary functionBaseline, Week 8

Pulmonary function (FVC and FEV1) will be conducted on all subjects using a calibrated computerized pneumotachograph spirometer (Spirotouch; Burdick, Inc., Deerfield, Wisconsin USA.) according to American Thoracic Society (ATS) recommendations (Laszlo G., 2006).

Changes from baseline in peak nasal inspiratory flowBaseline, Week 8

Peak nasal inspiratory flow (PNIF) will be measured using a peak nasal inspiratory flow meter (Clement Clark International model IN-CHECK ORAL, UK.) attached to an anesthesia mask. During the procedure, the subjects placed a mask over the nose and mouth and inspired forcefully through the nose, with lips tightly closed. PNIF will be measured before and after exercise.

Changes from baseline in cardiorespiratory fitness (VO2max)Baseline, Week 8

VO2max will be performed using bruce treadmill protocol. Subjects will be asked to run on a treadmill (Landice, USA) in which the grade and intensity will be increased every 3 minutes until exhaustion.

Changes from baseline in nasal blood flowBaseline, week 8

Nasal mucosa blood flow will be measured by laser doppler flowmetry (DRT4 moor instrument, UK.). A side delivery endoscopic probe with flexible nylon sleeve with a diameter of 1.34 mm was placed on the anterior surface of the nose. The nasal blood flow values before and after exercise in each protocol will be then measured.

Trial Locations

Locations (1)

Faculty of Sports Science, Chulalongkorn University

🇹🇭

Patumwan, Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath